Sherwood Therapeutics
 
 
Developing novel wound care products
 
Home
Publications Contact:

Horobin AJ, Shakesheff KM, Pritchard DI.  Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions.  J Invest Dermatol 2006; 126 (6): 1410-8.

Pritchard DI.  Immune modulation by Pseudomonas aeruginosa quorum sensing signal molecules.  Int J Med Microbiol 2006; 296: 111-6.

Horobin AJ, Shakesheff KM, Pritchard DI.  Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface.  Wound Rep Regen 2005; 13 (4): 422-33.

Pritchard DI.  Sourcing a chemical succession for cyclosporin from parasites and human pathogens.  Drug Discovery Today 2005; 10: 688-91

Chambers L, Woodrow S, Brown AP, Harris PD, Phillips D, Hall M, Church JCT, Pritchard DI.  Degradation of extracellular matrix components by defined proteases from the greenbottle fly larva Lucilia sericata used for chemical debridement of non-healing wounds.  Br J Dermatol 2003; 148: 14-23.

Horobin AJ, Shakesheff KM, Woodrow S, Robinson C, Pritchard DI.  Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components.  Br J Dermatol 2003; 148: 923-33.

CEO

Dr Nigel Davis

Tel: 07711 983344

email: nigel.davis@

sherwoodtherapeutics.com